U.S. airlines stand to reap the benefits as more passengers slim down thanks to the popularity of GLP-1 weight-loss drugs.

But alongside dramatic changes, users are now flagging an unexpected effect that has sparked concern among doctors and ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects healthy upside for Novo Nordisk stock through ...

Millions of people are now using weight-loss drugs, but it seems there are side-effects that come with the slimmer waistlines ...

Executives reiterated that affordability remains a core pillar of Dr. Reddy’s India playbook, though they stopped short of ...

We look at the Novo Nordisk A/S outlook for 2026: new CEO focus, oral Wegovy edge vs Eli Lilly, and double-digit growth ...

Kelly Osbourne has sparked 'deadly eating disorder' fears as she continues to 'waste away' while grieving Ozzy's death.

Slimmed-down Seinfeld star Wayne Knight revealed he dropped 110 pounds not by going the Ozempic route – but by eating ...

The American Heart Association recommends systemic solutions beyond diet, exercise, and costly weight-loss drugs to address the social, economic, and environmental barriers that drive obesity, which ...

The surge of interest in using peptides is grounded more in wishful thinking than science. The recent preoccupation with peptides driven by online influencers is a classic example of a craze. Health ...

Valerie Bertinelli is reflecting on a painful memory. The Drew Barrymore Show lifestyle correspondent recently reflected on ...

Low energy and “Ozempic face” can be the downsides for people on GLP-1s, the increasingly popular drugs that go by the names Ozemic, Wegovy and Mounjaro.